Quest Diagnostics Total Current Assets 2010-2024 | DGX

Quest Diagnostics total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Quest Diagnostics total current assets for the quarter ending June 30, 2024 were $2.017B, a 16.39% increase year-over-year.
  • Quest Diagnostics total current assets for 2023 were $2.372B, a 24.97% increase from 2022.
  • Quest Diagnostics total current assets for 2022 were $1.898B, a 30.76% decline from 2021.
  • Quest Diagnostics total current assets for 2021 were $2.741B, a 10.37% decline from 2020.
Quest Diagnostics Annual Total Current Assets
(Millions of US $)
2023 $2,372
2022 $1,898
2021 $2,741
2020 $3,058
2019 $2,490
2018 $1,390
2017 $1,306
2016 $1,531
2015 $1,501
2014 $1,603
2013 $1,383
2012 $1,561
2011 $1,401
2010 $1,605
2009 $1,679
Quest Diagnostics Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $2,017
2024-03-31 $2,228
2023-12-31 $2,372
2023-09-30 $1,815
2023-06-30 $1,733
2023-03-31 $1,814
2022-12-31 $1,898
2022-09-30 $2,334
2022-06-30 $2,426
2022-03-31 $2,475
2021-12-31 $2,741
2021-09-30 $2,854
2021-06-30 $2,146
2021-03-31 $2,999
2020-12-31 $3,058
2020-09-30 $3,348
2020-06-30 $2,380
2020-03-31 $1,560
2019-12-31 $2,490
2019-09-30 $1,779
2019-06-30 $1,566
2019-03-31 $1,778
2018-12-31 $1,390
2018-09-30 $1,603
2018-06-30 $1,415
2018-03-31 $1,371
2017-12-31 $1,306
2017-09-30 $1,544
2017-06-30 $1,500
2017-03-31 $1,558
2016-12-31 $1,531
2016-09-30 $1,642
2016-06-30 $1,510
2016-03-31 $1,493
2015-12-31 $1,501
2015-09-30 $1,648
2015-06-30 $1,530
2015-03-31 $2,375
2014-12-31 $1,603
2014-09-30 $1,563
2014-06-30 $1,505
2014-03-31 $1,488
2013-12-31 $1,383
2013-09-30 $1,426
2013-06-30 $1,470
2013-03-31 $1,457
2012-12-31 $1,561
2012-09-30 $1,472
2012-06-30 $1,477
2012-03-31 $1,519
2011-12-31 $1,401
2011-09-30 $1,396
2011-06-30 $1,478
2011-03-31 $2,300
2010-12-31 $1,605
2010-09-30 $1,553
2010-06-30 $1,631
2010-03-31 $1,645
2009-12-31 $1,679
2009-09-30 $1,471
2009-06-30 $1,339
2009-03-31 $1,485
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.308B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00